Get breaking ophthalmic news, device and drug updates, clinical trial coverage, thought-leader perspective, and industry announcements.

X-Cel Specialty Contacts and Essilor Custom Contacts have launched Lunara, an FDA PMA-approved overnight orthokeratology lens made from 180 Dk Optimum Infinite material Lunara uses familiar tangential ...

Sightview has launched an updated EHR and practice management platform designed specifically for ophthalmology practices The platform introduces a redesigned interface, streamlined workflows, an ...

A Bayesian meta-analysis of 54 studies and more than 6.8 million cataract surgeries found antibiotic injection was associated with an approximately 79% reduction in the odds of postoperative ...

Key Takeaways Orbis' first Flying Eye Hospital simulation project in Macau will train 70 ophthalmologists and nurses from ...

Key Takeaways Interim phase 1b findings showed ophthalmic responses in 3 of 5 evaluable Chinese participants, with individual ...

Get breaking ophthalmic news, device and drug updates, clinical trial coverage, thought-leader perspective, and industry ...

Get breaking ophthalmic news, device and drug updates, clinical trial coverage, thought-leader perspective, and industry ...

Get breaking ophthalmic news, device and drug updates, clinical trial coverage, thought-leader perspective, and industry ...

AbbVie and Regenxbio announced a partnership to develop and commercialize RGX-314, a potential one-time gene therapy for the treatment of wet age-related macular degeneration (AMD), diabetic ...

https://eyewire.news/news/nanoscope-initiates-rolling-submission-of-bla-to-fda-for-mco-010-the-first-gene-agnostic-therapy-to-treat-rp Nanoscope Therapeutics ...